(Q43815790)

English

Comparison of disk diffusion, E-test and broth microdilution test in determination of susceptibility of Aspergillus species to amphotericin B, itraconazole and voriconazole

scientific article published in February 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Comparison of disk diffusion, E-test and broth microdilution test in determination of susceptibility of Aspergillus species to amphotericin B, itraconazole and voriconazole (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1 reference

based on heuristic

inferred from title

object named as

Aspergillus

1 reference

based on heuristic

inferred from title

author name string

Ozkutuk A

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Ergon C

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Metin DY

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Yucesoy M

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Polat SH

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

publication date

1 February 2008

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Journal of Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

87-92

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Aspergillus susceptibility testing in patients with cancer and invasive aspergillosis: difficulties in establishing correlation between in vitro susceptibility data and the outcome of initial amphotericin B therapy

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.1.87

21 January 2018

Aspergillosis caused by non-fumigatus Aspergillus species: risk factors and in vitro susceptibility compared with Aspergillus fumigatus

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.1.87

21 January 2018

Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy.

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.1.87

21 January 2018

Utility of mould susceptibility testing

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.1.87

21 January 2018

Comparative evaluation of disk diffusion with microdilution assay in susceptibility testing of caspofungin against Aspergillus and Fusarium isolates

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.1.87

21 January 2018

New agents for treatment of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.1.87

21 January 2018

Acquired itraconazole resistance in Aspergillus fumigatus

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.1.87

21 January 2018

Susceptibility testing of Aspergillus flavus: inoculum dependence with itraconazole and lack of correlation between susceptibility to amphotericin B in vitro and outcome in vivo

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.1.87

21 January 2018

Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B.

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.1.87

21 January 2018

Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.1.87

21 January 2018

Has antifungal susceptibility testing come of age?

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.1.87

21 January 2018

Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp.

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.1.87

21 January 2018

Comparison of the Etest and the sensititre colorimetric methods with the NCCLS proposed standard for antifungal susceptibility testing of Aspergillus species

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.1.87

21 January 2018

Intrinsic in vitro susceptibility of primary clinical isolates of Aspergillus fumigatus, Aspergillus terreus, Aspergillus nidulans, Candida albicans and Candida lusitaniae against amphotericin B.

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.1.87

21 January 2018

Comparison of three commercial assays and a modified disk diffusion assay with two broth microdilution reference assays for testing zygomycetes, Aspergillus spp., Candida spp., and Cryptococcus neoformans with posaconazole and amphotericin B.

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.1.87

21 January 2018

Identifiers

10.1179/JOC.2008.20.1.87

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43815790&oldid=2161392659"